Anti-Spinocerebellar Ataxia Type 3 Antibody, clone 1H9

Anti-Spinocerebellar Ataxia Type 3 Antibody, clone 1H9 化学特性,用途語,生産方法

• 使用

  Immunohistochemistry:
  A 1:500-1:5000 dilution of a previous lot was used in IH.
  
  Immunoprecipitation:
  A 1:500-1:5000 dilution of a previous lot was used in IP.
  
  ELISA:
  A 1:500-1:5000 dilution of a previous lot was used in ELISA.
  
  Immunocytochemistry:
  A 1:500-1:5000 dilution of a previous lot was used in IC.
  
  Optimal working dilutions must be determined by the end user.

• 一般的な説明

  Spinocerebellar ataxia (SCA) is a genetic disease with multiple types, each of which could be considered a disease in its own right.
  Spinocerebellar ataxia (SCA) is one of a group of genetic disorders characterized by slowly progressive incoordination of gait and often associated with poor coordination of hands, speech, and eye movements. Frequently, atrophy of the cerebellum occurs. The first ataxia gene was identified in 1993 for a dominantly inherited type called “Spinocerebellar ataxia type 1" (SCA1). Subsequently, as additional dominant genes were found they were called SCA2, SCA3, etc. Usually, the "type" number of "SCA" refers to the order in which the gene was found. At this time, there are at least 29 different gene mutations which have been found.

Anti-Spinocerebellar Ataxia Type 3 Antibody, clone 1H9 生産企業

Global(2)Suppliers